The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action
Open accessAbstract
Neurological and neurodegenerative diseases, particularly those related to aging, are on the rise, but drug therapies are rarely curative. Functional disorders and the organic degeneration of nervous tissue often have complex causes, in which phenomena of oxidative stress, inflammation and cytotoxicity are intertwined. For these reasons, the search for natural substances that can slow down or counteract these pathologies has increased rapidly over the last two decades. In this paper, studies on the neuroprotective effects of flavonoids (especially the two most widely used, hesperidin and quercetin) on animal models of depression, neurotoxicity, Alzheimer’s disease (AD) and Parkinson’s disease are reviewed. The literature on these topics amounts to a few hundred publications on in vitro and in vivo models (notably in rodents) and provides us with a very detailed picture of the action mechanisms and targets of these substances. These include the decrease in enzymes that produce reactive oxygen and ferroptosis, the inhibition of mono-amine oxidases, the stimulation of the Nrf2/ARE system, the induction of brain-derived neurotrophic factor production and, in the case of AD, the prevention of amyloid-beta aggregation. The inhibition of neuroinflammatory processes has been documented as a decrease in cytokine formation (mainly TNF-alpha and IL-1beta) by microglia and astrocytes, by modulating a number of regulatory proteins such as Nf-kB and NLRP3/inflammasome. Although clinical trials on humans are still scarce, preclinical studies allow us to consider hesperidin, quercetin, and other flavonoids as very interesting and safe dietary molecules to be further investigated as complementary treatments in order to prevent neurodegenerative diseases or to moderate their deleterious effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737 · cited 1×
“It is estimated that this challenging condition affects 15–20% of the world’s population [103].”
BackgroundNeuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044 · cited 2×
“In neurology, vicious circles like these can run a rapid, acute course (such as in stroke or trauma) or a chronic course (such as in AD and PD [28,29]), as well as produce functional neurological disorders.”
BackgroundInflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836 · cited 1×
“NLRP3 inflammasome is the most highly expressed member in microglia, and the excessive activation of the NLRP3 inflammasome is involved in the pathogenesis of many brain disorders, including trauma, ischemia and major depressive disorder, as well as PD [195].”
BackgroundDietary patterns and depression risk: a meta-analysis
Li, Y., Lv, M.-R., Wei, Y.-J., Sun, L., Zhang, J.-X., Zhang, H.-G., & Li, B. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.020 · Cited by 599
Interaction between flavonoids and the blood–brain barrier: in vitro studies
Youdim, K. A., Dobbie, M. S., Kuhnle, G., Proteggente, A. R., Abbott, N. J., & Rice‐Evans, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01652.x · Cited by 578
Rahimifard, M., Maqbool, F., Moeini-Nodeh, S., Niaz, K., Abdollahi, M., Braidy, N., Nabavi, S. M., & Nabavi, S. F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.02.004 · Cited by 481
Anti-inflammatory Effects of Flavonoids in Neurodegenerative Disorders
Spagnuolo, C., Moccia, S., & Russo, G. L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.001 · Cited by 458
The endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils
Della Bianca, V., Dusi, S., Bianchini, E., Dal Prà, I., & Rossi, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15493 · Cited by 324 · cited 1×
“Activated microglia are an important type of innate immune cell in the brain that secrete inflammatory cytokines into the extracellular environment, where they exert neurotoxicity on surrounding neurons by releasing nitric oxide [35,36], and are involved in the pathogenesis of many brain disorders, including AD [37].”
BackgroundIslam, M. T., Tuday, E., Allen, S., Kim, J., Trott, D. W., Holland, W. L., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.13767 · Cited by 313 · cited 1×
“cerevisiae [347], human keratinocytes [348,349], adipocytes [350,351], fibroblasts [352], umbilical vein endothelial cells [353] and the intervertebral disc (nucleus pulposus) [354].”
BackgroundManagement of oxidative stress and other pathologies in Alzheimer’s disease
Simunkova, M., Alwasel, S. H., Alhazza, I. M., Jomova, K., Kollar, V., Rusko, M., & Valko, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02538-y · Cited by 303
Quercetin pharmacokinetics in humans
Moon, Y. J., Wang, L., DiCenzo, R., & Morris, M. E. (2008) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.605 · Cited by 287 · cited 1×
“Although the bioavailability of quercetin can vary according to the type of food and according to the intestinal metabolism, by means of dietary supplementation, it is possible to increase the plasma concentration of quercetin [89,90].”
BackgroundAluminium in brain tissue in familial Alzheimer’s disease
Mirza, A., King, A., Troakes, C., & Exley, C. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.12.001 · Cited by 261
Beneficial Effects of Flavonoids Against Parkinson's Disease
Jung, U. J., & Kim, S. R. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4078 · Cited by 150
Sharma, D. R., Wani, W. Y., Sunkaria, A., Kandimalla, R. J., Sharma, R. K., Verma, D., Bal, A., & Gill, K. D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.055 · Cited by 144
Park, M., Choi, J., & Lee, H.-J. (2020) · Nutrients · doi:10.3390/nu12061815 · Cited by 139 · cited 1×
“Considering the bidirectional communications between the intestine and the brain, a study examined the changes in the intestinal bacterial flora following the intake of flavonoidrich orange juice [119] in a group of subjects with symptoms of depression.”
BackgroundSAMAD, N., SALEEM, A., YASMIN, F., & SHEHZAD, M. A. (2018) · Physiological Research · doi:10.33549/physiolres.933776 · Cited by 130 · cited 1×
“Less lipid peroxidation and decreased acetylcholinesterase (AChE), while acetylcholine levels were increased [168]”
BackgroundLi, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., Zhang, J., & Yang, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.020 · Cited by 129
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Maguire, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00083 · Cited by 113
Magnesium in Human Health and Disease
(2013) · doi:10.1007/978-1-62703-044-1 · Cited by 108
Zoico, E., Nori, N., Darra, E., Tebon, M., Rizzatti, V., Policastro, G., De Caro, A., Rossi, A. P., Fantin, F., & Zamboni, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02544-0 · Cited by 94 · cited 1×
“cerevisiae [347], human keratinocytes [348,349], adipocytes [350,351], fibroblasts [352], umbilical vein endothelial cells [353] and the intervertebral disc (nucleus pulposus) [354].”
BackgroundHenríquez, G., Gomez, A., Guerrero, E., & Narayan, M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00381 · Cited by 83
Malavolta, M., Pierpaoli, E., Giacconi, R., Costarelli, L., Piacenza, F., Basso, A., Cardelli, M., & Provinciali, M. (2016) · Current Drug Targets · doi:10.2174/1389450116666150907105104 · Cited by 68
Novel Nutraceutical Compounds in Alzheimer Prevention
Maccioni, R. B., Calfío, C., González, A., & Lüttges, V. (2022) · Biomolecules · doi:10.3390/biom12020249 · Cited by 45
Molaei, A., Hatami, H., Dehghan, G., Sadeghian, R., & Khajehnasiri, N. (2020) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2019-2082 · Cited by 41
Cited by
Flavonoids and their role in oxidative stress, inflammation, and human diseases
Jomova, K., Alomar, S. Y., Valko, R., Liska, J., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111489 · Cited by 362
Kim, S. B., Ryu, H. Y., Nam, W., Lee, S. M., Jang, M. R., Kwak, Y. G., Kang, G. I., Song, K. S., & Lee, J. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216444 · Cited by 8
Metadata
- Authors
- Bellavite, P.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2023-01-27
- Volume
- 12
- Issue
- 2
- Pages
- 280
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W4318479370
- Cited by
- 212
- References
- 27
- FWCI
- 27.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.